BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7534136)

  • 21. Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system.
    Arp J; Ford CM; Palker TJ; King EE; Dekaban GA
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():211-22. PubMed ID: 8429302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.
    Wallace LE; Wright J; Ulaeto DO; Morgan AJ; Rickinson AB
    J Virol; 1991 Jul; 65(7):3821-8. PubMed ID: 1710291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.
    Matsushita S; Robert-Guroff M; Trepel J; Cossman J; Mitsuya H; Broder S
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2672-6. PubMed ID: 2422659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.
    Blanchard S; Astier-Gin T; Tallet B; Moynet D; Londos-Gagliardi D; Guillemain B
    J Virol; 1999 Nov; 73(11):9369-76. PubMed ID: 10516045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
    J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.
    Lairmore MD; Rudolph DL; Roberts BD; Dezzutti CS; Lal RB
    Cancer Lett; 1992 Sep; 66(1):11-20. PubMed ID: 1360328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
    J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
    Lal RB; Rudolph DL; Kaplan JE; Hjelle B; Levine PH; Coligan JE; Viscidi RP
    Virology; 1992 Jan; 186(1):274-9. PubMed ID: 1727602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
    Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
    J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
    Tallet B; Astier-Gin T; Moynet D; Londos-Gagliardi D; Guillemain B
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):337-48. PubMed ID: 11242520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes.
    Loughran TP; Hadlock KG; Yang Q; Perzova R; Zambello R; Semenzato G; Foung SK; Poiesz BJ
    Blood; 1997 Sep; 90(5):1977-81. PubMed ID: 9292532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
    Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
    J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Goon PK; Hanon E; Igakura T; Tanaka Y; Weber JN; Taylor GP; Bangham CR
    Blood; 2002 May; 99(9):3335-41. PubMed ID: 11964301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations.
    Buckner C; Roberts CR; Foung SK; Lipka J; Reyes GR; Hadlock K; Chan L; Gongora-Biachi RA; Hjelle B; Lal RB
    J Infect Dis; 1992 Nov; 166(5):1160-3. PubMed ID: 1383353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration of antibodies to human T-cell lymphotropic virus-I tax in patients with the cutaneous T-cell lymphoma, mycosis fungoides, who are seronegative for antibodies to the structural proteins of the virus.
    Pancake BA; Wassef EH; Zucker-Franklin D
    Blood; 1996 Oct; 88(8):3004-9. PubMed ID: 8874198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical involvement of human T cell leukaemia virus type I virions in mediating the viral mitogenic effect.
    Cassé H; Girerd Y; Gazzolo L; Duc Dodon M
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1909-16. PubMed ID: 8046393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
    Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response.
    Pique C; Connan F; Levilain JP; Choppin J; Dokhélar MC
    J Virol; 1996 Aug; 70(8):4919-26. PubMed ID: 8763995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.